Molecular motions in HIV-1 gp120 mutants reveal their preferences for different conformations

被引:12
|
作者
Liu, Shu-Qun
Liu, Ci-Qun
Fu, Yun-Xin [1 ]
机构
[1] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Kunming 650091, Peoples R China
[2] Univ Texas, Hlth Sci Ctr, Ctr Human Genet, Houston, TX 77030 USA
来源
关键词
gp120; mutants; conformational transition; essential dynamics; essential subspace overlap; mutation effect;
D O I
10.1016/j.jmgm.2006.12.007
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Both the crystal structures of the HIV-1 gp120 core bound by the CD4 and antigen 17b, and the SIV gp 120 core pre-bound by CD4 are known. We built the homology models of gp 120 with loops V3 and V4 in the CD4-complex, CD4-free and CD4-unliganded states, and models of the 375 S/ W and 423 I/P mutants in the CD4-free and unliganded states, respectively. CONCOORD was utilized for generating ensembles of the seven gp 120 models that were analyzed by essential dynamics analyses to identify their preferred concerted motions. The revealed large-scale concerted motions are related to either the receptor association/release or the conformational transition between different conformational states. Essential subspace overlap analyses were performed to quantitatively distinguish the preference for conformational transitions between states of the gp120 Mutants and further to ascertain what kind of conformational state that the mutants prefer to adopt. Results indicate that the 375 S/W mutant, in which the tryptophan indole group is predicted to occupy the phe43 pocket in the gp120 interior, favors a conformation close to the CD4-bound state. However, the other mutant 423 UP inclines to prevent the formation of bridging sheet and stabilize the conformation in the unliganded state. Our theoretical analyses are in agreement with experimentally determined mutation effects, and can be extended to a new approach to design or screen mutants that have effects on conformation/function of a protein. (C) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:306 / 318
页数:13
相关论文
共 50 条
  • [21] COMPLEMENT ACTIVATION BY RECOMBINANT HIV-1 GLYCOPROTEIN GP120
    SUSAL, C
    KIRSCHFINK, M
    KROPELIN, M
    DANIEL, V
    OPELZ, G
    JOURNAL OF IMMUNOLOGY, 1994, 152 (12): : 6028 - 6034
  • [22] Probing the conformational control mechanism of HIV-1 gp120: a molecular simulation study
    Sang, Peng
    Liu, Shu-Qun
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2015, 33 : 125 - 126
  • [23] HLA MIMICRY BY HIV-1 GP120 IN THE PATHOGENESIS OF AIDS
    HABESHAW, JA
    IMMUNOLOGY TODAY, 1994, 15 (01): : 39 - 40
  • [24] HIV-1 gp120: A Target for Therapeutics and Vaccine Design
    Cicala, Claudia
    Nawaz, Fatima
    Jelicic, Katija
    Arthos, James
    Fauci, Anthony S.
    CURRENT DRUG TARGETS, 2016, 17 (01) : 122 - 135
  • [25] MONOCLONAL-ANTIBODIES TO HIV-1 GP120 - A REQUEST
    MOORE, J
    SATTENTAU, Q
    JAMESON, B
    SODROSKI, J
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 (07) : 695 - 695
  • [26] Intracellular signalling mediating HIV-1 gp120 neurotoxicity
    Scorziello, A
    Florio, T
    Bajetto, A
    Schettini, G
    CELLULAR SIGNALLING, 1998, 10 (02) : 75 - 84
  • [27] DIFFERENTIAL-EFFECTS OF HIV-1 GP120 ON THYMOCYTES
    OYAIZU, N
    CHIRMULE, N
    YAGURA, H
    SUGIURA, K
    MCCLOSKEY, T
    KALYANARAMAN, VS
    PAHWA, S
    FASEB JOURNAL, 1992, 6 (05): : A1978 - A1978
  • [28] CHARACTERISTICS OF HIV-1 GP120 GLYCOPROTEIN BINDING TO GLYCOLIPIDS
    MCALARNEY, T
    APOSTOLSKI, S
    LEDERMAN, S
    LATOV, N
    JOURNAL OF NEUROSCIENCE RESEARCH, 1994, 37 (04) : 453 - 460
  • [29] Inhibitory effects of HIV-1 gp120 on myelin formation
    KimuraKuroda, J
    Nagashima, K
    Yasui, K
    PERSPECTIVES IN DRUG DISCOVERY AND DESIGN, 1996, 5 : 17 - 29
  • [30] Search for nearly invariant segments in HIV-1 gp120
    Wu, TT
    Johnson, G
    BIOPHYSICAL JOURNAL, 2003, 84 (02) : 282A - 282A